Anixa Biosciences Announces Presentations of Two Clinical-Stage Immunotherapy Programs at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium

Go back to Anixa Biosciences Announces Presentations of Two Clinical-Stage Immunotherapy Programs at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium
(NASDAQ: ANIX) Delayed: 2.76 -0.01 (0.36%)
Previous Close $2.77    52 Week High
Open $2.74    52 Week Low
Day High $2.87    P/E N/A 
Day Low $2.70    EPS
Volume 126,654